Yizhe Wang
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker.
Journal: Frontiers in oncology
Published: June 09, 2026
Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma.
Journal: Biomarker research
Published: May 12, 2023
Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways.
Journal: Journal of translational internal medicine
Published: February 09, 2022
Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 08, 2021
Corrigendum: CircHIPK3 Promotes Metastasis of Gastric Cancer via miR-653-5p/miR-338-3p-NRP1 Axis Under a Long-Term Hypoxic Microenvironment.
Journal: Frontiers in oncology
Published: September 29, 2021
Correction to: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma.
Journal: Biomarker research
Published: April 15, 2021
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: February 07, 2021
Impact of Chinese respiratory physicians participating in smoking cessation and mobile health: A randomised feasibility trial.
Journal: The clinical respiratory journal
Published: December 20, 2020
LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma.
Journal: Biomarker research
Published: December 17, 2020
Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation.
Journal: Frontiers in cell and developmental biology
Published: October 27, 2020
Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer.
Journal: Frontiers in oncology
Published: October 22, 2020
Last Updated: 09/26/2026